Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
dc.contributor.author | Adnan, A. | |
dc.contributor.author | Basu, Sandip | |
dc.date.accessioned | 2024-02-09T07:40:23Z | |
dc.date.available | 2024-02-09T07:40:23Z | |
dc.date.issued | 2023 | |
dc.description.division | RMC | en |
dc.format.extent | 4768 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Diagnostics, 2023. Vol. 13: Article no. 2154 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/26419 | |
dc.language.iso | en | en |
dc.subject | SSTR PET-CT | en |
dc.subject | somatostatin receptor | en |
dc.subject | neuroendocrine neoplasm | en |
dc.subject | theranostics | en |
dc.subject | gastroenteropancreatic | en |
dc.subject | precision oncology | en |
dc.subject | 68Ga-DOTA-TATE PET-CT | en |
dc.title | Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms | en |
dc.type | Article | en |